Results 11 to 20 of about 110,071 (192)
mRNA vaccines for cancer immunotherapy [PDF]
Frontiers in Immunology, 2022 Immunotherapy has emerged as a breakthrough strategy in cancer treatment. mRNA vaccines are an attractive and powerful immunotherapeutic platform against cancer because of their high potency, specificity, versatility, rapid and large-scale development ...
Yashavantha L. Vishweshwaraiah +4 more
doaj +4 more sources
In Vitro Transcribed RNA-Based Platform Vaccines: Past, Present, and Future
Vaccines, 2023 mRNA was discovered in 1961, but it was not used as a vaccine until after three decades. Recently, the development of mRNA vaccine technology gained great impetus from the pursuit of vaccines against COVID-19.
Alexey D. Perenkov +3 more
doaj +2 more sources
mRNA vaccines: a new era in vaccine development
Oncology ResearchThe advent of RNA therapy, particularly through the development of mRNA cancer vaccines, has ushered in a new era in the field of oncology. This article provides a concise overview of the key principles, recent advancements, and potential implications of mRNA cancer vaccines as a groundbreaking modality in cancer treatment.
Chandra, Shubhra +3 more
openaire +5 more sources
From Design to Clinical Use: mRNA Vaccines for Infectious Diseases and Cancer [PDF]
VaccinesmRNA vaccines represent a revolutionary advance in vaccinology, boasting advantages like rapid development, robust immunogenicity and flexible antigen design over traditional vaccines.
Yulin Cui, Ziyue Liang, Hua Cong
doaj +2 more sources
The advances of adjuvants in mRNA vaccines
npj Vaccines, 2023 The remarkable success of messenger RNA (mRNA) vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has propelled the rapid development of this vaccination technology in recent years. Over the last three decades, numerous studies
Chunyuan Xie, Ruhui Yao, Xiaojun Xia
doaj +3 more sources
Immunogenic Comparison of Nucleic Acid-Based Vaccines Administered by Pyro-Drive Jet Injector
VaccinesmRNA vaccines were successfully developed and approved for emergency use to fight coronavirus disease 2019. However, the effect of DNA vaccines against SARS-CoV-2 is considerably lower than that of mRNA vaccines.
Jiayu A. Tai +5 more
doaj +2 more sources
Nanotechnology-Enabled COVID-19 mRNA Vaccines
Encyclopedia, 2021 COVID-19 mRNA vaccines contain synthetic mRNA sequences encoded for the Spike proteins expressed on the surface of SARS-CoV-2, and utilize the host cells to produce specific antigens that stimulate both humoral and cellular immunities.
Yu Gao +3 more
doaj +1 more source
, 2022 mRNA vaccines have been increasingly recognized as a powerful vaccine platform since the FDA approval of two COVID-19 mRNA vaccines, which demonstrated outstanding prevention efficacy as well as great safety profile. Notably, nucleoside modification and lipid nanoparticle-facilitated delivery has greatly improved the immunogenicity, stability, and ...
Li, Mengyun +3 more
openaire +2 more sources
Development and Delivery Systems of mRNA Vaccines
Frontiers in Bioengineering and Biotechnology, 2021 Since the outbreak of SARS-CoV-2, mRNA vaccine development has undergone a tremendous drive within the pharmaceutical field. In recent years, great progress has been made into mRNA vaccine development, especially in individualized tumor vaccines.
Yongjun Liang, Liping Huang, Tiancai Liu
doaj +1 more source
From mRNA sensing to vaccines [PDF]
Immunity, 2021 The 2005 Immunity paper by Karikó et al. has been hailed as a cornerstone insight that directly led to the design and delivery of the mRNA vaccines against COVID-19. We asked experts in pathogen sensing, vaccine development, and public health to provide their perspective on the study and its implications.
Fauci, Anthony S. +8 more
openaire +2 more sources